✦ LIBER ✦

The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase

✍ Scribed by Khosravan, Reza; Grabowski, Brian A.; Mayer, Michael D.; Wu, Jing-Tao; Joseph-Ridge, Nancy; Vernillet, Laurent

Book ID: 119969476
Publisher: Sage Publications
Year: 2006
Tongue: English
Weight: 239 KB
Volume: 46
Category: Article
ISSN: 0091-2700
DOI: 10.1177/0091270005282634

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effect of Age and Gender on Pharmaco

The Effect of Age and Gender on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase

✍ Khosravan, Reza; Kukulka, Michael J.; Wu, Jing-Tao; Joseph-Ridge, Nancy; Vernill 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 222 KB

Effect of hydrochlorothiazide on the pha

Effect of hydrochlorothiazide on the pharmacokinetics and pharmacodynamics of febuxostat, a non-purine selective inhibitor of xanthine oxidase

✍ Brian Grabowski; Reza Khosravan; Jing-Tao Wu; Laurent Vernillet; Christopher Lad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

Efficacy and Safety of Febuxostat, a Nov

Efficacy and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase for the Treatment of Hyperuricemia in Kidney Transplant Recipients

✍ Tojimbara, T.; Nakajima, I.; Yashima, J.; Fuchinoue, S.; Teraoka, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Pharmacokinetics, Pharmacodynamics and S

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

✍ Dr Reza Khosravan, Brian A. Grabowski, Jing-Tao Wu, Nancy Joseph-Ridge, Laurent 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 268 KB

The effect of mild and moderate hepatic

The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor

✍ Nenad Sarapa; Margaret R. Britto; Michelle B. Mainka; Kourosh Parivar 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 325 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Febuxostat (TMX‐67), a Non‐Purine Selective Inhibitor of Xanthine Oxidase/Xanthine Dehydrogenase (NPSIXO) in Patients with Gout and/or Hyperuricemia

✍ Komoriya, K.; Hoshide, S.; Takeda, K.; Kobayashi, H.; Kubo, J.; Tsuchimoto, M.; 📂 Article 📅 2004 🏛 Taylor and Francis Group 🌐 English ⚖ 97 KB